Clinical trial
Effect of EGCG on the Body's Response to Insulin
NCT00434499 · University of Maryland, Baltimore, Other · Withdrawn
Key facts
| NCT number | NCT00434499 |
|---|---|
| Title | Effect of EGCG on the Body's Response to Insulin |
| Official title | An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy and Obese Subjects |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension, Obesity, Type 2 Diabetes, Insulin Resistance |
| Intervention type | Drug |
| Interventions | EGCG |
| Enrollment | 0 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Feb 13, 2007 |
| Last update posted | Mar 4, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: